Issued Patents All Time
Showing 25 most recent of 41 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12258430 | Compositions and methods for labeling and modulation of cells in vitro and in vivo | David J. Mooney | 2025-03-25 |
| 12145913 | Inhibition of Olig2 activity | Graham Beaton, Stanton McHardy, Ambrosio Lopez, Jr., Bismarck CAMPOS | 2024-11-19 |
| 12071409 | Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) and uses thereof | Stanley Watowich, Harshini Neelakantan, Stanton McHardy | 2024-08-27 |
| 12031136 | Treatment for skeletal diseases caused by intracellular protein trafficking defects | Yuji Kondo, Jianxin Fu, Klaas Wierenga, Patrick M. Gaffney, Lijun Xia | 2024-07-09 |
| 11952330 | Antibiotic ammonium compounds and methods for the treatment of bacterial infections | Bryan Davies, Stanton McHardy, Ashley Cunningham | 2024-04-09 |
| 11891439 | Antibodies and assays for CCL14 | Ravi Vijayendran | 2024-02-06 |
| 11878970 | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease | Erin Danielle ANDERSON, Sean Aronow, Nicholas Boyles, Xiaohong Chen, Surendra DAWADI +12 more | 2024-01-23 |
| 11873295 | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease | Erin Danielle ANDERSON, Sean Aronow, Nicholas Boyles, Surendra DAWADI, Eugene Richard Hickey +13 more | 2024-01-16 |
| 11691951 | Inhibition of Olig2 activity | Graham Beaton, Fabio Tucci, Satheesh B. Ravula, Stanton McHardy, Francisco Xavier RUIZ +2 more | 2023-07-04 |
| 11685722 | Inhibition of Olig2 activity | Graham Beaton, Stanton McHardy, Ambrosio Lopez, Jr., Bismarck CAMPOS | 2023-06-27 |
| 11590182 | Methods and compositions to modulate antibiotic resistance and gastrointestinal microbiota | Lu Zhang, Yang Zhou, Zihua Wang | 2023-02-28 |
| 11401243 | Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) and uses thereof | Stanley Watowich, Harshini Neelakantan, Stanton McHardy | 2022-08-02 |
| 11376324 | Sting activating nanovaccine for immunotherapy | Jinming Gao, Zhijian Chen, Min Luo, Zhaohui Wang, Haocheng Cai +2 more | 2022-07-05 |
| 11291286 | Cosmetic compositions with a micro-mesh structure | Snehal M. Shah, Zhequan Xu, Mary Ann Smail, Milan F. Sojka, Daniela Bratescu | 2022-04-05 |
| 11242323 | Inhibition of OLIG2 activity | Graham Beaton, Stanton McHardy, Ambrosio Lopez, Jr., Bismarck CAMPOS | 2022-02-08 |
| 11014953 | Trigger-activatable metabolic sugar precursors for cancer-selective labeling and targeting | Jianjun Cheng | 2021-05-25 |
| 11014974 | Non-antibody binding proteins binding to PD-1 receptors and uses thereof | Xiaofeng Huang, Long Zhao, Yan Zhang | 2021-05-25 |
| 10954262 | Tunicamycin analogues | Benjamin G. Davis, Filip Wyszynski | 2021-03-23 |
| 10828605 | Reverse osmosis system for use with a wellbore and methods of assembling the same | Hareesh Kumar Reddy Kommepalli, Andrew Philip Shapiro | 2020-11-10 |
| 10702557 | Combined external medicine for treating prostate diseases | Jian He | 2020-07-07 |
| 10660420 | Cosmetic compositions | Snehal M. Shah, Zhequan Xu, Mary Ann Smail, Milan F. Sojka, Daniela Bratescu | 2020-05-26 |
| 10660419 | Packaged skin treatment composition and method | Osvaldo Fontanet, Paul Abbatepaolo, Jennifer Fuller, Jennifer Palmer Quintano, Snehal M. Shah +2 more | 2020-05-26 |
| 10314790 | Sustained-release formulations of topiramate | Likan Liang, Padmanabh P. Bhatt, Michael L. Vieira | 2019-06-11 |
| 10227333 | Inhibition of OLIG2 activity | Graham Beaton, Fabio Tucci, Satheesh B. Ravula | 2019-03-12 |
| 10206972 | Anti-vascular disease and antitumor pharmaceutical composition and use thereof | Huanchun Liang | 2019-02-19 |